Norvir data

Abbott's protease inhibitor showed antiviral action after 60 weeks of combined therapy with AZT and ddC, according to results presented at the International Conference on AIDS in Vancouver. In the open-label French trial, first reported in February, 17 patients with advanced, previously untreated AIDS and CD4 counts <250, improved to show counts of 337, with viral load reduced almost 2 logs from baseline. The number of infectious blood cells also fell by more than 2 logs. ...